Eagle Claw Capital Managment, LLC Charles River Laboratories International, Inc. Transaction History
Eagle Claw Capital Managment, LLC
- $538 Million
- Q1 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 15,805 shares of CRL stock, worth $3.26 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
15,805
Previous 16,115
1.92%
Holding current value
$3.26 Million
Previous $3.81 Million
12.42%
% of portfolio
0.8%
Previous 0.81%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
727Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.25 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.07 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$433 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$388 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$313 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.5B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...